Owkin
About
Owkin is an AI company focused on solving the complexity of biology to accelerate drug discovery and development. They leverage federated learning and AI to analyze sensitive patient data securely and at scale, enabling better understanding of diseases and identification of new therapeutic targets. Owkin also incubates and spins out companies to bring AI innovations to specific market needs.
Key facts
At-a-glance profile data
- Website
- owkin.com
- Headquarters
- New York, New York, USA
- Founded
- 2016
- Employees
- 250
- Total funding
- $80M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 1 Jun 2022 | Series B | $80M | $1.0B | Bristol-Myers Squibb |
Tech stack
Detected on owkin.com, last scanned 21 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager, Hotjar
- Support
- Zendesk
- CMS / Builders
- Webflow, GitBook
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Cookie consent
- Cookiebot
Add first review
Frequently asked
How much funding has Owkin raised?
Owkin has raised a total of $80M in funding. The most recent round on record is Series B.
How many employees does Owkin have?
Owkin has approximately 250 people on record.